GSK’s risky business in China
British pharmaceutical giant GlaxoSmithKline (GSK) has been embroiled in bribery probes in China. In the last few days the Chinese authorities have revealed details of the alleged fraudulent practices at the pharma giant, even before a criminal investigation is concluded. Yesterday (15 July), lead investigator, Gao Feng, alleged that GSK had funnelled more than RMB3bn […]